UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q/A
(Mark One)
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2018
or
o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from__________ to _________
Commission File Number 000-52534
PARALLAX HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Nevada | 46-4733512 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
|
|
1327 Ocean Avenue, Suite B, Santa Monica, CA | 90401 |
(Address of principal executive offices) | (Zip Code) |
|
|
Registrant's telephone number, including area code: | (310) 899-4442 |
Copy of all Communications to:
Peter Hogan, Esq.
Buchalter
1000 Wilshire Blvd., Suite 1500
Los Angeles, CA 90017
(213) 891-0700
Large accelerated filer | ☐ |
| Accelerated filer | ☐ |
Non-accelerated filer | ☐ |
| Smaller reporting company | ☑ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). | Yes ☐ No ☑ |
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
152,178,141 common shares issued and outstanding as of November 14, 2018
This Amendment No. 1 to the Annual Report on Form 10-Q/A for the quarterly period ending September 30, 2018, is being filed solely to furnish the Interactive Data files as Exhibit 101, in accordance with Rule 405 of Regulation S-T. No other changes have been made to the Form 10-K, as originally filed on November 14, 2018.
ITEM 6. EXHIBITS
Exhibits required by Item 601 of Regulation S-B
Exhibit Number | Description of Exhibit | Filing Reference |
(100) | XBRL Related Documents | |
101.INS** | XBRL Instance Document | Filed herewith. |
101.SCH** | XBRL Taxonomy Extension Schema Document | Filed herewith. |
101.CAL** | XBRL Taxonomy Extension Calculation Linkbase Document | Filed herewith. |
101.LAB** | XBRL Taxonomy Extension Labels Linkbase Document | Filed herewith. |
101.PRE** | XBRL Taxonomy Extension Presentation Linkbase Document | Filed herewith. |
101.DEF** | XBRL Taxonomy Extension Definition Linkbase Document | Filed herewith. |
*Filed herewith.
**Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
| PARALLAX HEALTH SCIENCES, INC. |
|
|
|
|
|
|
|
|
|
| Dated: November 15, 2018 | /s/ Paul R. Arena |
|
|
| Paul R. Arena |
|
|
| Chief Executive Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dated: November 15, 2018 | /s/ Calli R. Bucci |
|
|
| Calli R. Bucci |
|
|
| Chief Financial Officer |
|
|
|
|
|